MAE-WEST SCORE Career Enhance Core

MAE-WEST SCORE 职业提升核心

基本信息

  • 批准号:
    10450757
  • 负责人:
  • 金额:
    $ 14.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Abstract – MAE-WEST SCORE CEC Over the course of life, chronic stressors contribute to multi-organ aging and dysfunction and, ultimately, the development of clinical disease. Sex remains a critical determinant of the nature and pace of aging and ultimately longevity. With advancing chronologic age in humans, differences in biological aging between women and men become even more pronounced, culminating in the female predominance for a number of important morbid disease conditions, including notably Alzheimer’s disease and related dementias (ADRD), heart failure with preserved ejection fraction (HFpEF), progressive chronic kidney disease (CKD), and in turn systemic frailty. Mechanisms underlying the female predominance for these major morbidities remains unknown and are not explained by variations in sex hormones or survival bias. Our preliminary work supports a central hypothesis that sexual dimorphism in inflammatory eicosanoid mediators contribute to sex differences in microvascular dysfunction and, in turn, to sex differences in age-related multi-organ disease, including for ADRD, HFpEF and CKD. Elucidating a common pathophysiologic basis for the female predominance of ADRD, HFpEF, and CKD holds the key to effective interventions for reducing the excess burden of age-related disease in women. Motivated our findings and the critical need to understand the determinants and drivers of sex differences in major age-related disease outcomes, we propose to establish the Microvascular Aging and Eicosanoids – Women’s Evaluation of Systemic aging Tenacity (MAE-WEST) (“You are never too old to become younger!”) Specialized Center of Research Excellence (SCORE) on Sex Differences, in response to NIH RFA-OD-19-013. Our goal is to form a robust and sustainable structure of academic activities centered on systematically interrogating sex differences in the relationship among eicosanoids, microvascular dysfunction, and age-related end-organ disease, with an initial focus on the microvascular aging effects on brain, heart, and kidney function. This goal will be achieved by an outstanding collaborative team of clinician-scientists (with expertise in geriatrics, cardiology, and nephrology), epidemiologists, basic and translational scientists, analytical chemists, biostatisticians, and bioinformaticians. Leveraging our collective experience, resources, and infrastructure, we will advance the scientific enterprise through 3 foundational projects aligned and complementary yet independent. To promote and enhance the development of the next generation of early career investigators who are committed to studying sex differences in biomedicine, our MAE-WEST SCORE program will provide a robust, multi-disciplinary Career Enhancement Core. Methodological expertise areas include: epidemiology, clinical trials, basic science, analytical chemistry, biostatistics and bioinformatics, neurocognitive testing, integrated physiology, and global functional assessments. Content and clinical areas of expertise that will maximize the potential for translation of research findings to practice include: geriatrics and gerontology, neurology and neuro- ophthalmology, cardiology, nephrology, and women’s health.
项目摘要 – MAE-WEST SCORE CEC 在生命过程中,慢性压力源会导致多器官衰老和功能障碍,并最终导致 性别仍然是衰老的性质和速度的关键决定因素。 随着人类实际年龄的增长,女性和男性之间的生物衰老存在差异。 变得更加明显,最终导致许多重要病态的女性占主导地位 疾病状况,特别是阿尔茨海默氏病和相关痴呆症 (ADRD)、心力衰竭 射血分数保留(HFpEF)、进行性慢性肾病(CKD)以及全身虚弱。 这些主要疾病的女性占主导地位的机制仍然未知,也不明确 我们的初步工作支持一个中心假设: 炎症类二十烷酸介质的性别二态性导致微血管的性别差异 功能障碍,进而导致与年龄相关的多器官疾病的性别差异,包括 ADRD、HFpEF 和 阐明 ADRD、HFpEF 和 CKD 女性占主导地位的共同病理生理学基础 是采取有效干预措施减少妇女因年龄相关疾病而过度负担的关键。 激发了我们的发现以及了解性别差异的决定因素和驱动因素的迫切需要 主要的年龄相关疾病结果,我们建议建立微血管衰老和类二十烷酸 – 女性系统衰老韧性评估(MAE-WEST)(“你永远不会太老,不会变得更年轻!”) 性别差异专业卓越研究中心 (SCORE),响应 NIH RFA-OD-19-013。 我们的目标是形成一个稳健且可持续的学术活动结构,以系统地为中心 探讨类二十烷酸、微血管功能障碍和年龄相关性之间关系的性别差异 终末器官疾病,最初关注微血管老化对大脑、心脏和肾脏功能的影响。 这一目标将由杰出的临床医生科学家合作团队(具有老年病学、 心脏病学和肾病学)、流行病学家、基础和转化科学家、分析化学家、 我们利用生物统计学家和生物信息学家的集体经验、资源和基础设施。 将通过 3 个相互协调且互补的基础项目推进科学事业 促进和加强下一代早期职业调查员的发展。 致力于研究生物医学中的性别差异,我们的 MAE-WEST SCORE 计划将提供强大的、 多学科职业提升核心方法论专业领域包括:流行病学、临床。 试验、基础科学、分析化学、生物统计学和生物信息学、神经认知测试、综合 生理学、整体功能评估的内容和临床领域的专业知识,将最大限度地发挥作用。 将研究成果转化为实践的潜力包括:老年病学和老年学、神经病学和神经病学 眼科、心脏病学、肾病学和妇女健康。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cathleen Noel Bairey Merz其他文献

Cathleen Noel Bairey Merz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cathleen Noel Bairey Merz', 18)}}的其他基金

MAE-WEST SCORE Project 2 Clinical
MAE-WEST SCORE 项目 2 临床
  • 批准号:
    10198761
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
MAE-WEST SCORE Leadership Administrative Core
MAE-WEST SCORE 领导力行政核心
  • 批准号:
    10198756
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
  • 批准号:
    10817498
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
MAE-WEST SCORE Leadership Administrative Core
MAE-WEST SCORE 领导力行政核心
  • 批准号:
    10450756
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
  • 批准号:
    10198755
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
MAE-WEST SCORE Project 2 Clinical
MAE-WEST SCORE 项目 2 临床
  • 批准号:
    10450762
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
  • 批准号:
    10450755
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
MAE-WEST SCORE Career Enhance Core
MAE-WEST SCORE 职业提升核心
  • 批准号:
    10198757
  • 财政年份:
    2020
  • 资助金额:
    $ 14.25万
  • 项目类别:
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
女性缺血综合征评估 (WISE) - 冠状动脉微血管功能障碍导致射血分数保留 (HFpEF) 的先兆心力衰竭的机制
  • 批准号:
    10576287
  • 财政年份:
    2019
  • 资助金额:
    $ 14.25万
  • 项目类别:
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
女性缺血综合征评估 (WISE) - 冠状动脉微血管功能障碍导致射血分数保留 (HFpEF) 的先兆心力衰竭的机制
  • 批准号:
    9922714
  • 财政年份:
    2019
  • 资助金额:
    $ 14.25万
  • 项目类别:

相似海外基金

Access to medical care and health care utilization among low-income immigrants
低收入移民获得医疗保健的机会和医疗保健利用
  • 批准号:
    10789176
  • 财政年份:
    2023
  • 资助金额:
    $ 14.25万
  • 项目类别:
Prototype System for AML Digital Twins
AML 数字孪生原型系统
  • 批准号:
    10588076
  • 财政年份:
    2023
  • 资助金额:
    $ 14.25万
  • 项目类别:
School Counselors and Children's Mental Health
学校辅导员和儿童心理健康
  • 批准号:
    10573995
  • 财政年份:
    2023
  • 资助金额:
    $ 14.25万
  • 项目类别:
NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS (CCMV) INFECTION
先天性巨细胞病毒 (CCMV) 感染的新生儿筛查随访研究
  • 批准号:
    10937099
  • 财政年份:
    2023
  • 资助金额:
    $ 14.25万
  • 项目类别:
Inter-CFAR Women and HIV Biennial Symposium
Inter-CFAR 妇女与艾滋病毒双年研讨会
  • 批准号:
    10762305
  • 财政年份:
    2023
  • 资助金额:
    $ 14.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了